Skip to main content

Crystallization Development

 Developing a robust crystallization process to isolate the optimal solid form of an API is an essential step in API development. Identifying the crystallization approach, solvent system(s), controlling form, crystal habit and delivering a consistent uniform PSD from a single process step can be very challenging.

Applying expertise in, solid state, PAT and computational modelling all underpin our development of crystallization processes, allowing us to deliver the best outcome at the required scale. We also work on remediating existing crystallizations, which can have a variety of issues such as oiling out, isolating the wrong polymorphic form or just long filtration times.

Understanding the crystallization behaviour of a molecule can help:

  • Maximise process yields
  • Improve purity
  • Control form, morphology and particle size distribution
  • Create processes suitable for transfer and scale-up
  • Strengthen IP
Man in crystallization development lab

The key to controlled, growth-dominated crystallization is a thorough understanding of the solubility and metastable zone width (MSZW) of the system in combination with knowledge of the nucleation and growth kinetics. Once this understanding is acquired by experimental techniques, PAT and modeling, the process can be optimized to target crystal growth and avoid unwanted nucleation events (route 2).

 

Pictorial representation of different crystallization pathways with respect to solubility and MSZWPictorial representation of different crystallization pathways with respect to solubility and MSZW

 

The arrival of advanced high-resolution PAT such as the BlazeMetrics™ probe gives previously unattainable insights into both existing and novel crystallization processes. A combination of high-resolution microscopy and Raman spectroscopy allows the formation and growth of transient forms to be pinpointed and the materials identified in situ.

Raman spectroscopy of a polymorphic transition

 

In situ imaging of a polymorphic transition

In situ Raman spectroscopy and imaging of a polymorphic transition from a metastable form with rhombohedral morphology to a stable form with fibrous morphology.

Through advanced characterization tools, our experienced team of scientists are able to examine crystallization systems at reduced scales. Chord length measurements and in situ images can be used to validate crystal growth models at a small scale. Breakage, aggregation, and secondary nucleation can all be assessed throughout the scale-up process and these events are factored into predictive models during method transfer from vessel to vessel.

Our experts are trained not only in the art of crystallization, but also in solid form science, modeling, PAT, and particle sizing.

Popular posts from this blog

Polymorph, Salt & Cocrystal Screening

 Selecting the optimal solid form of an API during early drug development can mitigate the risk of failure later in development. This can be achieved through polymorph, salt and cocrystal screening. Polymorph screening  aims to identify all relevant forms of an API, investigate their properties and choose the optimal crystalline form. Polymorphism control is exceptionally important and conducting these screens can help prevent the appearance of new forms in the latter stages of development. We focus on establishing the interconversions between forms, the relative stability of forms and understanding the monotropic or enantiotropic relationship between polymorphs when required. Polymorph screening is a regulatory requirement whether a salt, cocrystal or free form compound is chosen for development. Salt screening  is an approach to quickly identify and assess the salt forms of an API. This allows drug developers to modify the physical properties of an API while preserving ...